Unverdi S, Ceri M, Köklü S, Unverdi H, Koçak E, Duranay M

Language: English
References: 7
Page: 372-373
PDF size: 23.31 Kb.

Text Extraction

To the Editor,

The relation between HBV and glomerulonephritis including membranous and mesengio-proliferative glomerulonephritis has been well documented. However, only six cases of HBV associated focal segmental glomerulosclerosis (FSGS) were reported previously. Reduction of HBV DNA titers is important for remission of HBV-associated glomerulopathies. We herein represent a case of HBV-associated FSGS who relapsed under lamivudine therapy and improved with tenofovir treatment. We reviewed the pertinent literature regarding HBV-associated FSGS.

REFERENCES

1. Lai ASH, Lai KN. Viral nephropathy. Nat Clin Pract Nephrol 2006; 2: 254-62.

2. Khaira A, Upadhyay BK, Sharma A, et al. Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature. Clin Exp Nephrol 2009; 13: 373-7.

3. Sakallioglu O, Gok F, Kalman S, et al. Hepatitis B complicated focal segmental glomerulosclerosis. J Nephrol 2005; 18: 433-5.

4. Herberth J, Herberth Z, Abul-Ezz SR, et al. Hepatitis B infection as a possible cause of focal segmental glomerular sclerosis. Clin Nephrol 2006; 65: 380-4.

5. Takaki A, Nakatsuka A, Satou C, et al. A case of focal segmental glomerulosclerosis (FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis. Nippon Jinzo Gakkai Shi 2002; 44: 806-12.

6. Izzedine H, Massard J, Poynard T, et al. Lamivudine and HBV-associated nephropathy. Nephrol Dial Transplant 2006; 21: 828-9.

7. Lai MY, Yang WC, Lee SD, et al. Long-term lamivudine therapy is not reasonable for HBV-associated nephropathy. Nephrol Dial Transplant 2006; 21: 1740-1.